Explore News
-
Why Teens Choose Surgery for Weight Loss
New study findings on cost-effectiveness of gastric bypass and sleeve gastrectomy
-
Why Ozempic Matters for Weight Loss
Experts predict a future of combined therapies for long-term results
-
Fasting after 60: What You Need to Know
Intermittent fasting’s effects on health change significantly after age 60, posing unexpected risks
-
NIH Study Reveals Why 70% of Wegovy Users Hit Plateaus
New NIH research uncovers brain-level resistance to GLP-1 drugs like Ozempic and Wegovy, explaining weight…
-
70% of Patients Achieve Weight Loss with Semaglutide Post-Surgery
New research reveals that semaglutide, a GLP-1 receptor agonist, significantly aids weight loss in patients…
-
Retatrutide Yields 28% Weight Loss in 80 Weeks
Eli Lilly’s experimental drug retatrutide led to unprecedented weight reduction in trial participants, signaling a…
-
GLP-1 Medications Reduce Cardiovascular Risk by 20%
A landmark global study finds that GLP-1 drugs significantly lower the risk of heart attacks,…
-
78% of Users Report Reduced Food Cravings on GLP-1s
New research illuminates how drugs like Ozempic and Mounjaro suppress ‘food noise,’ transforming the way…
-
Ozempic Weight Loss Tied to Major Health Benefits, Study Reveals
New research shows that patients who lost the most weight on GLP-1 drugs like Ozempic…
-
GLP-1 Drugs Reshape Obesity Care, New Guidelines Urge Dietitian-Led Approach
New international consensus emphasizes multidisciplinary care as GLP-1 medications surge in use, highlighting the critic
